BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fontana F, Cazzato S, Giovanella S, Ballestri M, Leonelli M, Mori G, Alfano G, Ligabue G, Magistroni R, Cenacchi G, Antoniotti R, Bonucchi D, Cappelli G. Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19. Kidney Int Rep 2020;5:1815-22. [PMID: 32838081 DOI: 10.1016/j.ekir.2020.07.008] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
Number Citing Articles
1 Nattawat Klomjit, Ladan Zand, Lynn D Cornell, Mariam Priya Alexander. COVID-19 and glomerular diseases. Kidney Int Rep 2023. [ DOI: 10.1016/j.ekir.2023.03.016] [Reference Citation Analysis]
2 Kafi F, Mortazavi M, Pouramini A, Dolatkhah S, Kaleidari B, Taheri D. Secondary oxalate nephropathy and impact of high-dose vitamin C intake for COVID-19 prevention on a patient with Roux-en-Y gastric bypass: A case report. Clin Case Rep 2023;11:e7020. [PMID: 36911630 DOI: 10.1002/ccr3.7020] [Reference Citation Analysis]
3 Kędzierska-Kapuza K, Szczuko U, Stolińska H, Bakaloudi DR, Wierzba W, Szczuko M. Demand for Water-Soluble Vitamins in a Group of Patients with CKD versus Interventions and Supplementation-A Systematic Review. Nutrients 2023;15. [PMID: 36839219 DOI: 10.3390/nu15040860] [Reference Citation Analysis]
4 Roy S, Chourasia P, Sangani V, Errabelli PK, Patel SS, Adapa S. Megadose Vitamin C Prescription Through Alternative Medicine Leading to End-Stage Renal Disease: Case Study and Literature Review. J Investig Med High Impact Case Rep 2023;11:23247096231158954. [PMID: 36914980 DOI: 10.1177/23247096231158954] [Reference Citation Analysis]
5 Chary MA, Barbuto AF, Izadmehr S, Tarsillo M, Fleischer E, Burns MM. COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Xenobiotics). J Med Toxicol 2023;19:26-36. [PMID: 36525217 DOI: 10.1007/s13181-022-00918-y] [Reference Citation Analysis]
6 Sae-Khow K, Charoensappakit A, Chiewchengchol D, Leelahavanichkul A. High-Dose Intravenous Ascorbate in Sepsis, a Pro-Oxidant Enhanced Microbicidal Activity and the Effect on Neutrophil Functions. Biomedicines 2022;11. [PMID: 36672559 DOI: 10.3390/biomedicines11010051] [Reference Citation Analysis]
7 Mehta N, Pokharna P, Shetty SR. Unwinding the potentials of vitamin C in COVID-19 and other diseases: An updated review. Nutr Health 2022. [DOI: 10.1177/02601060221139628] [Reference Citation Analysis]
8 Fong P, Wusirika R, Rueda J, Raphael KL, Rehman S, Stack M, de Mattos A, Gupta R, Michels K, Khoury FG, Kung V, Andeen NK. Increased Rates of Supplement-Associated Oxalate Nephropathy During COVID-19 Pandemic. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.09.002] [Reference Citation Analysis]
9 du Preez HN, Aldous C, Kruger HG, Johnson L. N-Acetylcysteine and Other Sulfur-Donors as a Preventative and Adjunct Therapy for COVID-19. Advances in Pharmacological and Pharmaceutical Sciences 2022;2022:1-21. [DOI: 10.1155/2022/4555490] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Firouzi S, Pahlavani N, Navashenaq JG, Clayton ZS, Beigmohammadi MT, Malekahmadi M. The effect of Vitamin C and Zn supplementation on the immune system and clinical outcomes in COVID-19 patients. Clin Nutr Open Sci 2022;44:144-54. [PMID: 35783349 DOI: 10.1016/j.nutos.2022.06.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Lam WK, Ha CY, Yip SF. Ascorbic Acid Therapy in Hematological Malignancies - The Current Knowledge and Future Directions.. [DOI: 10.32388/pmlz1t.5] [Reference Citation Analysis]
12 Lin L, Chen Y, Han D, Yang A, Wang AY, Qi W. Cardiorenal Syndrome in COVID-19 Patients: A Systematic Review. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.915533] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Chugh D, Bishnoi M. SARS-CoV-2 and Therapeutic Approaches. TOCOVIDJ 2022;2. [DOI: 10.2174/26669587-v2-e2204260] [Reference Citation Analysis]
14 Lam WK, Ha CY, Yip SF. Ascorbic Acid Therapy in Hematological Malignancies - The Current Knowledge and Future Directions.. [DOI: 10.32388/pmlz1t.4] [Reference Citation Analysis]
15 He W, Liu X, Hu B, Li D, Chen L, Li Y, Tu Y, Xiong S, Wang G, Deng J, Fu B. Mechanisms of SARS-CoV-2 Infection-Induced Kidney Injury: A Literature Review. Front Cell Infect Microbiol 2022;12:838213. [DOI: 10.3389/fcimb.2022.838213] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Hess AL, Halalau A, Dokter JJ, Paydawy TS, Karabon P, Bastani A, Baker RE, Balla AK, Galens SA. High-dose intravenous vitamin C decreases rates of mechanical ventilation and cardiac arrest in severe COVID-19. Intern Emerg Med. [DOI: 10.1007/s11739-022-02954-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Copur S, Berkkan M, Basile C, Tuttle K, Kanbay M. Post-acute COVID-19 syndrome and kidney diseases: what do we know? J Nephrol 2022. [PMID: 35294747 DOI: 10.1007/s40620-022-01296-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
18 Gambella A, Barreca A, Biancone L, Roccatello D, Peruzzi L, Besso L, Licata C, Attanasio A, Papotti M, Cassoni P. Spectrum of Kidney Injury Following COVID-19 Disease: Renal Biopsy Findings in a Single Italian Pathology Service. Biomolecules 2022;12:298. [DOI: 10.3390/biom12020298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
19 Rosenstock JL, Joab TMJ, DeVita MV, Yang Y, Sharma PD, Bijol V. Oxalate nephropathy: a review. Clin Kidney J 2022;15:194-204. [PMID: 35145635 DOI: 10.1093/ckj/sfab145] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
20 Egbuche O, Abe T, Nwokike SI, Jegede O, Mezue K, Olanipekun T, Onuorah I, Echols MR. Racial differences in cardiopulmonary outcomes of hospitalized COVID-19 patients with acute kidney injury. Rev Cardiovasc Med 2021;22:1667-75. [PMID: 34957809 DOI: 10.31083/j.rcm2204174] [Reference Citation Analysis]
21 Jandaghi P, Hosseini Z, Chilibeck P, Hanley AJ, Deguire JR, Bandy B, Pahwa P, Vatanparast H. The Role of Immunomodulatory Nutrients in Alleviating Complications Related to SARS-CoV-2: A Scoping Review. Adv Nutr 2021;13:424-38. [PMID: 34932789 DOI: 10.1093/advances/nmab128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 du Preez HN, Aldous C, Hayden MR, Kruger HG, Lin J. Pathogenesis of COVID-19 described through the lens of an undersulfated and degraded epithelial and endothelial glycocalyx. FASEB J 2022;36:e22052. [PMID: 34862979 DOI: 10.1096/fj.202101100RR] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
23 Gholizadeh M, Ghafour Saeedy SA, Abdi A, Khademi F, Lorian K, Clark CC, Djafarian K. Vitamin C reduces interleukin-6 plasma concentration: a systematic review and meta-analysis of randomized clinical trials. Clinical Nutrition Open Science 2021;40:1-14. [DOI: 10.1016/j.nutos.2021.09.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Jeyalan V, Storrar J, Wu HHL, Ponnusamy A, Sinha S, Kalra PA, Chinnadurai R. Native and transplant kidney histopathological manifestations in association with COVID-19 infection: A systematic review. World J Transplant 2021; 11(11): 480-502 [PMID: 34868898 DOI: 10.5500/wjt.v11.i11.480] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
25 Holford P, Carr AC, Zawari M, Vizcaychipi MP. Vitamin C Intervention for Critical COVID-19: A Pragmatic Review of the Current Level of Evidence. Life (Basel) 2021;11:1166. [PMID: 34833042 DOI: 10.3390/life11111166] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
26 Menez S, Parikh CR. Overview of acute kidney manifestations and management of patients with COVID-19. Am J Physiol Renal Physiol 2021;321:F403-10. [PMID: 34448642 DOI: 10.1152/ajprenal.00173.2021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 May RM, Cassol C, Hannoudi A, Larsen CP, Lerma E, Haun RS, Braga JR, Hassen SI, Wilson J, VanBeek C, Vankalakunti M, Barnum L, Walker PD, Bourne TD, Messias NC, Ambruzs JM, Boils CL, Sharma SS, Cossey LN, Baxi PV, Palmer M, Zuckerman J, Walavalkar V, Urisman A, Gallan A, Al-Rabadi LF, Rodby R, Luyckx V, Espino G, Santhana-Krishnan S, Alper B, Lam SG, Hannoudi GN, Matthew D, Belz M, Singer G, Kunaparaju S, Price D, Sauabh C, Rondla C, Abdalla MA, Britton ML, Paul S, Ranjit U, Bichu P, Williamson SR, Sharma Y, Gaspert A, Grosse P, Meyer I, Vasudev B, El Kassem M, Velez JCQ, Caza TN. A multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 Disease (COVID-19). Kidney Int 2021:S0085-2538(21)00734-1. [PMID: 34352311 DOI: 10.1016/j.kint.2021.07.015] [Cited by in Crossref: 35] [Cited by in F6Publishing: 19] [Article Influence: 17.5] [Reference Citation Analysis]
28 Alfano G, Ferrari A, Fontana F, Mori G, Magistroni R, Meschiari M, Franceschini E, Menozzi M, Cuomo G, Orlando G, Santoro A, Digaetano M, Puzzolante C, Carli F, Bedini A, Milic J, Coloretti I, Raggi P, Mussini C, Girardis M, Cappelli G, Guaraldi G; Modena Covid-19 Working Group (MoCo19). Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19. Clin Exp Nephrol 2021. [PMID: 34196877 DOI: 10.1007/s10157-021-02092-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
29 Smarz-Widelska I, Grywalska E, Morawska I, Forma A, Michalski A, Mertowski S, Hrynkiewicz R, Niedźwiedzka-Rystwej P, Korona-Glowniak I, Parczewski M, Załuska W. Pathophysiology and Clinical Manifestations of COVID-19-Related Acute Kidney Injury-The Current State of Knowledge and Future Perspectives. Int J Mol Sci 2021;22:7082. [PMID: 34209289 DOI: 10.3390/ijms22137082] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
30 Shi D, Yan R, Lv L, Jiang H, Lu Y, Sheng J, Xie J, Wu W, Xia J, Xu K, Gu S, Chen Y, Huang C, Guo J, Du Y, Li L. The serum metabolome of COVID-19 patients is distinctive and predictive. Metabolism 2021;118:154739. [PMID: 33662365 DOI: 10.1016/j.metabol.2021.154739] [Cited by in Crossref: 61] [Cited by in F6Publishing: 45] [Article Influence: 30.5] [Reference Citation Analysis]
31 Wissanji T, Dupuis ME, Royal V, Pichette V, Wang HT. Vitamin C-Induced Oxalate Nephropathy in a Septic Patient. Crit Care Explor 2021;3:e0389. [PMID: 33912831 DOI: 10.1097/CCE.0000000000000389] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Milani GP, Macchi M, Guz-Mark A. Vitamin C in the Treatment of COVID-19. Nutrients 2021;13:1172. [PMID: 33916257 DOI: 10.3390/nu13041172] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 12.0] [Reference Citation Analysis]
33 Anandh U, Gowrishankar S, Sharma A, Salama A, Dasgupta I. Kidney transplant dysfunction in a patient with COVID - 19 infection: role of concurrent Sars-Cov 2 nephropathy, chronic rejection and vitamin C-mediated hyperoxalosis: case report. BMC Nephrol 2021;22:91. [PMID: 33722190 DOI: 10.1186/s12882-021-02298-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
34 Sharma P, Ng JH, Bijol V, Jhaveri KD, Wanchoo R. Pathology of COVID-19-associated acute kidney injury. Clin Kidney J 2021;14:i30-9. [PMID: 33796284 DOI: 10.1093/ckj/sfab003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 14.5] [Reference Citation Analysis]
35 Mahling M, Köppen M, Mühlbacher T, Amann K, Königsrainer A, Heyne N, Häberle H, Nadalin S, Guthoff M. Acute Kidney Allograft Injury Following Vitamin C Administration for Septic Shock. Kidney Int Rep 2020;5:2114-8. [PMID: 33163733 DOI: 10.1016/j.ekir.2020.08.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Malhotra V, Magoon S, Troyer DA, McCune TR. Collapsing Focal Segmental Glomerulosclerosis and Acute Oxalate Nephropathy in a Patient With COVID-19: A Double Whammy. J Investig Med High Impact Case Rep 2020;8:2324709620963635. [PMID: 33019829 DOI: 10.1177/2324709620963635] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
37 Ascorbic acid. Reactions Weekly 2020;1821:47-47. [DOI: 10.1007/s40278-020-83167-4] [Reference Citation Analysis]
38 Ng JH, Bijol V, Sparks MA, Sise ME, Izzedine H, Jhaveri KD. Pathophysiology and Pathology of Acute Kidney Injury in Patients With COVID-19. Adv Chronic Kidney Dis 2020;27:365-76. [PMID: 33308501 DOI: 10.1053/j.ackd.2020.09.003] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 20.3] [Reference Citation Analysis]